These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


540 related items for PubMed ID: 17493532

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pre- and post-transplant monitoring of soluble CD30 levels as predictor of acute renal allograft rejection.
    Wang D, Wu GJ, Wu WZ, Yang SL, Chen JH, Wang H, Lin WH, Wang QH, Zeng ZX, Tan JM.
    Transpl Immunol; 2007 Jun; 17(4):278-82. PubMed ID: 17493531
    [Abstract] [Full Text] [Related]

  • 5. TH1/TH2 cytokines and soluble CD30 levels in kidney allograft patients with donor bone marrow cell infusion.
    Solgi G, Amirzagar AA, Pourmand G, Mehrsai AR, Taherimahmoudi M, Baradaran N, Nicknam MH, Ebrahimi Rad MR, Saraji A, Asadpoor AA, Moheiydin M, Nikbin B.
    Transplant Proc; 2009 Sep; 41(7):2800-4. PubMed ID: 19765439
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Soluble CD30 levels in recipients undergoing heart transplantation do not predict post-transplant outcome.
    Ypsilantis E, Key T, Bradley JA, Morgan CH, Tsui S, Parameshwar J, Taylor CJ.
    J Heart Lung Transplant; 2009 Nov; 28(11):1206-10. PubMed ID: 19782609
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pre-transplant soluble CD30 level as a predictor of not only acute rejection and graft loss but pneumonia in renal transplant recipients.
    Wang D, Wu WZ, Chen JH, Yang SL, Wang QH, Zeng ZX, Tan JM.
    Transpl Immunol; 2010 Feb; 22(3-4):115-20. PubMed ID: 20036333
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of pre- and posttransplantation serum interferon-gamma and soluble CD30 for predicting liver allograft rejection.
    Kim KH, Oh EJ, Jung ES, Park YJ, Choi JY, Kim DG, Lee KY, Kang CS.
    Transplant Proc; 2006 Jun; 38(5):1429-31. PubMed ID: 16797323
    [Abstract] [Full Text] [Related]

  • 13. High pretransplantation soluble CD30 levels: impact in renal transplantation.
    Giannoli C, Bonnet MC, Perrat G, Houillon A, Reydet S, Pouteil-Noble C, Villar E, Lefrançois N, Morelon E, Dubois V.
    Transplant Proc; 2007 Oct; 39(8):2574-5. PubMed ID: 17954178
    [Abstract] [Full Text] [Related]

  • 14. Identification of patients at risk of acute rejection by pretransplantation and posttransplantation monitoring of soluble CD30 levels in kidney transplantation.
    Sengul S, Keven K, Gormez U, Kutlay S, Erturk S, Erbay B.
    Transplantation; 2006 Apr 27; 81(8):1216-9. PubMed ID: 16641611
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Soluble CD30 in renal transplant recipients: is it a good biomarker to predict rejection?
    Azarpira N, Aghdaie MH, Malekpour Z.
    Saudi J Kidney Dis Transpl; 2010 Jan 27; 21(1):31-6. PubMed ID: 20061689
    [Abstract] [Full Text] [Related]

  • 17. Serial soluble CD30 measurements as a predictor of kidney graft outcome.
    Halim MA, Al-Otaibi T, Al-Muzairai I, Mansour M, Tawab KA, Awadain WH, Balaha MA, Said T, Nair P, Nampoory MR.
    Transplant Proc; 2010 Apr 27; 42(3):801-3. PubMed ID: 20430176
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. High serum soluble CD30 does not predict acute rejection in liver transplant patients.
    Matinlauri I, Höckerstedt K, Isoniemi H.
    Transplant Proc; 2006 Dec 27; 38(10):3601-4. PubMed ID: 17175343
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.